FDA approval Buspirone – Buspar clinical trails
Home       Treatment        Side Effects       Bristol Myers       FDA Aproval

 

FDA Approval for Buspirone – Buspar

The Food and Drug Administration of US has approved a new tranquilizer that treats anxiety without any major side effects. Mylan laboratories Inc. have received approval from the FDA (US) to market Buspirone. It is a leading generic pharmaceutical company in the world. Also it will become strong in the generic markets in future. This drug is significant and unique from other drugs. It is totally different from other tranquilizers which are in use. The drug Buspirone HCL will be sold in the market by the Bristol-Myers company instead of Buspar with the prescription.

The drug has undergone nearly 10 years of clinical trails and could replace valium in the treatment of anxiety. This drug has not been approved for the treatment of panic disorders. Bristol-Myers has announced that the drug Buspar has controlled the anxiety in the clinical trails without causing any drowsiness associated with other drugs. The main point to be noted is that the Buspar does not mix with the alcohol without any adverse effects that occurs with some other drugs. Buspar is a chemical compound which has been manufactured by Mead Johnson & Company from late 1960’s.

The manufacturer has said that the drug would produce some side effects such as drowsiness, dizziness which are not avoidable. Drugs for sale is an affiliate of Health solutions Network, LLC who are legally protected and the sale of the pills are done through online delivery. The pills are for the sale in US in different shapes and colors. There are some pills which look similar to that of the Buspirone except with the imprints being different.
 

Home       Treatment        Side Effects       Bristol Myers       FDA Aproval